PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.\', \'Harvard Medical School, Boston, Massachusetts, USA.\', \'Harvard Business School, Boston, Massachusetts, USA.\', \'Department of Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.\', \'Bureau of Infectious Disease and Laboratory Sciences, Massachusetts Department of Public Health, Boston, Massachusetts, USA.\', \'Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.\', \'Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/onco.13768
?:doi
?:hasPublicationType
?:journal
  • The oncologist
is ?:pmid of
?:pmid
?:pmid
  • 33783099
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Risk of COVID-19 in Patients with Cancer Receiving Immune Checkpoint Inhibitors.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33783099>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33783099>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all